Is Rad51D heterozygous mutation a contraindication to postmastectomy radiation?

Answer from: Radiation Oncologist at Community Practice

BRCA1/2, PALPB2, CHEK2, and RAD50/51 mutations should not affect radiation therapy https://www.redjournal.org/article/S0360-3016(19)33530-8/fulltext